UCB's Global Corporate Website

This section is intended for media and financial analysts

Search Press releases

31 May 2023

New Long-Term Data on Bimekizumab in Psoriatic Arthritis and Axial Spondyloarthritis Presented at EULAR 2023

Read More
30 May 2023

UCB Showcases Commitment to Advancing Care in Immune-Mediated Inflammatory Diseases with 23 Abstracts at EULAR 2023

Read More
26 May 2023

Transparency notification FMR LLC

Read More
23 May 2023

UCB and Veeva collaborate to advance the patient experience in clinical trials

Read More
11 May 2023

UCB and Ariceum Therapeutics sign a Strategic Research Collaboration to Discover New Modalities for the Treatment of Immune-related Diseases and Cancer

Read More
27 Apr 2023

UCB’s General Meeting of Shareholders 2023

Read More

Stay up-to-date on the latest news and information from UCB